Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 12, 2025, after the close
10-Q filed May 12, 2025, 42 days after period end · 0000950170-25-069204
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $250.00K | $0.00 |
| Net Income | -$2.23M | -$3.53M | -$2.34M | -$4.21M |
| EPS Diluted | -$0.47 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$4.59 |
| -$8.13 |
| -$12.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
